Bausch + Lomb Corp
BLCO15.190USD
-0.190-1.24%
收盘 09/19, 16:00（美东）报价延迟15分钟
5.37B总市值
亏损市盈率 TTM
关于 Bausch + Lomb Corp 公司
Bausch + Lomb Corporation 是一家眼保健公司。其业务分为三个部门：视力保健、制药和外科。视力保健部门包括隐形眼镜和消费者眼保健业务，包括隐形眼镜护理产品、非处方眼药水和眼部维生素。制药部门包括用于术后治疗和多种眼部疾病治疗的仿制药产品，例如青光眼、眼部炎症、眼高压、干眼症和视网膜疾病。外科部门包括用于治疗白内障、角膜和玻璃体以及视网膜眼部疾病的医疗器械设备、耗材、仪器和技术，其中包括输送系统、晶状体乳化设备和其他用于白内障手术的手术器械和设备。其品牌包括 PreserVision、Biotrue、Artelac、Alaway、Mioclear、Ocuvite、ScoutPro、XIIDRA、Vyzulta、Lotemax、Prolensa、Minims、INFUSE 等。
公司简介
公司代码BLCO
公司名称Bausch + Lomb Corp
上市日期May 06, 2022
CEOMr. Brenton L. (Brent) Saunders, J.D.
员工数量13500
证券类型Ordinary Share
年结日May 06
公司地址520 Applewood Crescent
城市VAUGHAN
上市交易所NYSE Consolidated
国家Canada
邮编L4K 4B4
电话19082552864
网址https://ir.bausch.com/
公司代码BLCO
上市日期May 06, 2022
CEOMr. Brenton L. (Brent) Saunders, J.D.
公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Brenton L. (Brent) Saunders, J.D.
Mr. Brenton L. (Brent) Saunders, J.D.
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
352.13K
+162.32%
Mr. Luc Bonnefoy
Mr. Luc Bonnefoy
President - Surgical
President - Surgical
77.36K
+8.63%
Dr. Yehia Hashad, M.D.
Dr. Yehia Hashad, M.D.
Executive Vice President - Research & Development, Chief Medical Officer
Executive Vice President - Research & Development, Chief Medical Officer
68.18K
+35.10%
Mr. Russel C. Robertson
Mr. Russel C. Robertson
Independent Director
Independent Director
64.91K
+53.22%
Dr. Andrew Charles Von Eschenbach, M.D.
Dr. Andrew Charles Von Eschenbach, M.D.
Independent Director
Independent Director
62.09K
+55.01%
Mr. A. Robert D. Bailey, J.D.
Mr. A. Robert D. Bailey, J.D.
Executive Vice President, Chief Legal Officer
Executive Vice President, Chief Legal Officer
--
--
Ms. Sarah B. Kavanagh
Ms. Sarah B. Kavanagh
Independent Director
Independent Director
--
--
Mrs. Nathalie Bernier
Mrs. Nathalie Bernier
Independent Director
Independent Director
--
--
Mr. Andrew J. Stewart
Mr. Andrew J. Stewart
President - Global Pharmaceuticals and International Consumer
President - Global Pharmaceuticals and International Consumer
--
--
Mr. Sam A. Eldessouky
Mr. Sam A. Eldessouky
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Brenton L. (Brent) Saunders, J.D.
Mr. Brenton L. (Brent) Saunders, J.D.
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
352.13K
+162.32%
Mr. Luc Bonnefoy
Mr. Luc Bonnefoy
President - Surgical
President - Surgical
77.36K
+8.63%
Dr. Yehia Hashad, M.D.
Dr. Yehia Hashad, M.D.
Executive Vice President - Research & Development, Chief Medical Officer
Executive Vice President - Research & Development, Chief Medical Officer
68.18K
+35.10%
Mr. Russel C. Robertson
Mr. Russel C. Robertson
Independent Director
Independent Director
64.91K
+53.22%
Dr. Andrew Charles Von Eschenbach, M.D.
Dr. Andrew Charles Von Eschenbach, M.D.
Independent Director
Independent Director
62.09K
+55.01%
Mr. A. Robert D. Bailey, J.D.
Mr. A. Robert D. Bailey, J.D.
Executive Vice President, Chief Legal Officer
Executive Vice President, Chief Legal Officer
--
--
收入明细
单位: USD更新时间: 7月6日 周日
单位: USD更新时间: 7月6日 周日
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
业务USD
名称
营收
占比
Devices
448.00M
39.40%
OTC
409.00M
35.97%
Pharmaceuticals
222.00M
19.53%
Branded and other Generics
54.00M
4.75%
Other revenues
4.00M
0.35%
暂无数据
业务
地区
业务USD
名称
营收
占比
Devices
448.00M
39.40%
OTC
409.00M
35.97%
Pharmaceuticals
222.00M
19.53%
Branded and other Generics
54.00M
4.75%
Other revenues
4.00M
0.35%
股东统计
更新时间: 8月18日 周一
更新时间: 8月18日 周一
持股股东
股东类型
持股股东
持股股东
占比
Bausch Health Companies Inc
87.69%
Icahn Associates Corporation
0.99%
Deutsche Bank Securities Inc.
0.96%
Alberta Investment Management Corporation
0.92%
D. E. Shaw & Co., L.P.
0.74%
其他
8.70%
持股股东
持股股东
占比
Bausch Health Companies Inc
87.69%
Icahn Associates Corporation
0.99%
Deutsche Bank Securities Inc.
0.96%
Alberta Investment Management Corporation
0.92%
D. E. Shaw & Co., L.P.
0.74%
其他
8.70%
股东类型
持股股东
占比
Corporation
87.70%
Hedge Fund
3.49%
Investment Advisor/Hedge Fund
3.32%
Research Firm
1.54%
Investment Advisor
1.53%
Sovereign Wealth Fund
0.92%
Individual Investor
0.48%
Pension Fund
0.25%
Family Office
0.24%
其他
0.54%
机构持股
更新时间: 7月1日 周二
更新时间: 7月1日 周二
报告期
机构数
持股数
持股占比
持股变动
2025Q2
263
350.71M
99.08%
-19.09M
2025Q1
273
350.60M
99.12%
-19.40M
2024Q4
262
347.48M
98.58%
-23.77M
2024Q3
257
349.38M
99.14%
-19.72M
2024Q2
260
352.10M
99.92%
-21.43M
2024Q1
247
349.79M
99.91%
-25.18M
2023Q4
237
351.31M
100.35%
-21.66M
2023Q3
219
355.43M
101.52%
-16.80M
2023Q2
207
357.28M
102.06%
-12.23M
2023Q1
194
356.91M
101.97%
-11.11M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
Bausch Health Companies Inc
310.45M
87.77%
--
--
Mar 24, 2025
Icahn Associates Corporation
3.50M
0.99%
--
--
Mar 31, 2025
Deutsche Bank Securities Inc.
3.50M
0.99%
+3.50M
--
Mar 31, 2025
Alberta Investment Management Corporation
3.27M
0.92%
+258.00K
+8.58%
Mar 31, 2025
D. E. Shaw & Co., L.P.
1.88M
0.53%
-6.18K
-0.33%
Mar 31, 2025
GoldenTree Asset Management, LP
2.25M
0.64%
+516.07K
+29.79%
Mar 31, 2025
Whitebox Advisors, L.L.C.
1.62M
0.46%
+179.78K
+12.46%
Mar 31, 2025
Nomura Securities Co., Ltd.
1.26M
0.36%
--
--
Mar 31, 2025
查看更多
持股ETF
更新时间: 9月6日 周六
更新时间: 9月6日 周六
机构名称
占比
Invesco RAFI Developed Mkts ex-US SM ETF
0%
Schwab Fundamental International Small Equity ETF
0%
BNY Mellon US Small Cap Core Equity ETF
0%
Goldman Sachs MarketBeta US 1000 Equity ETF
0%
Invesco Zacks Mid-Cap ETF
0%
First Trust US Equity Opportunities ETF
0%
DFA Dimensional International Core Equity 2 ETF
0%
Ballast Small/Mid Cap ETF
0%
Renaissance IPO ETF
0%
Invesco RAFI Developed Mkts ex-US SM ETF
占比0%
Schwab Fundamental International Small Equity ETF
占比0%
BNY Mellon US Small Cap Core Equity ETF
占比0%
Goldman Sachs MarketBeta US 1000 Equity ETF
占比0%
Invesco Zacks Mid-Cap ETF
占比0%
First Trust US Equity Opportunities ETF
占比0%
DFA Dimensional International Core Equity 2 ETF
占比0%
Ballast Small/Mid Cap ETF
占比0%
Renaissance IPO ETF
占比0%
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
